Ali Behbahani, Director: Adaptimmune Therapeutics ADAPY Sell · Filed 25/08/19

Trade details

Type: Insider sale
Amount: $146,717.94
Shares · price: 14,671,794 sh · $0.01 a share
Held after: 0 sh
Stock: Adaptimmune Therapeutics ADAPY
Person: Ali BehbahaniDirector
Trade date: 25/08/18
Filed: 25/08/19
Days to filing: 1 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Ali Behbahani's recent trades

Ali BehbahaniDirector
Planned saleCrispr Therapeutics
Planned sale
Crispr Therapeutics
CRSP
$780.9K
13,679 sh
$780.9K
Filed 09/17
Traded 09/17
Ali BehbahaniDirector
BuySpyGlass Pharma
Buy
SpyGlass Pharma
SGP
$15M
937,500 sh
$15M
Filed 02/11
Traded 02/09
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$16.6K
2,455 sh
$16.6K
Filed 25/10/06
Traded 25/10/02
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$1,890
280 sh
$1,890
Filed 25/10/06
Traded 25/10/02
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$6,075
900 sh
$6,075
Filed 25/10/06
Traded 25/10/02

Ali Behbahani, Director — sold $146.7K of Adaptimmune Therapeutics ADAPY · 100.0% of holdings | Whalegun